Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ostomor is a fixed-dose combination (FDC) oral tablet manufactured and marketed by Moral Pharmaceuticals Pvt Ltd. It is formulated to support bone health and prevent conditions such as osteoporosis. The product contains four active ingredients: calcium citrate, which provides a highly absorbable form of calcium; calcitriol (the active form of Vitamin D3), which facilitates calcium absorption from the gut; magnesium hydroxide, which aids in bone mineralization; and zinc sulphate, which supports bone-building cells and inhibits bone breakdown. This combination is typically used as a nutritional supplement to maintain bone density and function, particularly in populations at risk for bone loss.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ostomor.